XETRA - Delayed Quote EUR

Qiagen N.V. (QIA.DE)

Compare
44.66
-0.08
(-0.18%)
As of 10:36:57 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,966,174.00
1,965,311.00
2,141,518.00
2,251,657.00
1,870,346.00
Cost of Revenue
1,016,014.00
731,623.00
756,955.00
800,837.00
637,631.00
Gross Profit
950,160.00
1,233,688.00
1,384,563.00
1,450,820.00
1,232,715.00
Operating Expense
769,935.00
788,441.00
808,335.00
792,974.00
695,245.00
Operating Income
180,225.00
445,247.00
576,228.00
657,846.00
537,470.00
Net Non Operating Interest Income Expense
27,046.00
25,582.00
-25,600.00
-44,922.00
-61,285.00
Other Income Expense
-93,100.00
-41,020.00
-38,027.00
12,909.00
-36,713.00
Pretax Income
114,171.00
429,809.00
512,601.00
625,833.00
439,472.00
Tax Provision
21,238.00
88,506.00
89,390.00
113,234.00
80,284.00
Net Income Common Stockholders
92,933.00
341,303.00
423,211.00
512,599.00
359,188.00
Diluted NI Available to Com Stockholders
92,933.00
341,303.00
423,211.00
512,599.00
359,188.00
Basic EPS
0.46
1.55
1.92
2.33
0.33
Diluted EPS
0.45
1.53
1.90
2.28
0.32
Basic Average Shares
217,257.62
221,301.62
220,749.69
220,261.74
221,574.19
Diluted Average Shares
217,800.93
223,700.43
223,231.92
225,072.98
227,187.58
Total Operating Income as Reported
89,228.00
409,938.00
531,460.00
630,084.00
386,431.00
Total Expenses
1,785,949.00
1,520,064.00
1,565,290.00
1,593,811.00
1,332,876.00
Net Income from Continuing & Discontinued Operation
92,933.00
341,303.00
423,211.00
512,599.00
359,188.00
Normalized Income
167,002.81
369,338.35
460,189.37
535,336.08
482,586.86
Interest Income
72,185.00
78,992.00
32,757.00
9,555.00
10,032.00
Interest Expense
45,139.00
53,410.00
58,357.00
54,477.00
71,317.00
Net Interest Income
27,046.00
25,582.00
-25,600.00
-44,922.00
-61,285.00
EBIT
159,310.00
483,219.00
570,958.00
680,310.00
510,789.00
EBITDA
368,596.00
688,555.00
779,355.00
895,241.00
715,803.00
Reconciled Cost of Revenue
817,207.00
537,051.00
563,089.00
604,448.00
453,428.00
Reconciled Depreciation
209,286.00
205,336.00
208,397.00
214,931.00
205,014.00
Net Income from Continuing Operation Net Minority Interest
92,933.00
341,303.00
423,211.00
512,599.00
359,188.00
Total Unusual Items Excluding Goodwill
-90,997.00
-35,309.00
-44,768.00
-27,762.00
-151,039.00
Total Unusual Items
-90,997.00
-35,309.00
-44,768.00
-27,762.00
-151,039.00
Normalized EBITDA
459,593.00
723,864.00
824,123.00
923,003.00
866,842.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-16,927.19
-7,273.65
-7,789.63
-5,024.92
-27,640.14
12/31/2020 - 7/22/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESF0.DE Eurofins Scientific SE
48.82
0.00%
 
ILU.DE Illumina, Inc.
142.20
+1.05%
 
TN8.DE Thermo Fisher Scientific Inc.
543.00
-0.31%
 
NN6.DE NanoRepro AG
1.4700
0.00%
 
VIMIAN.ST Vimian Group AB (publ)
38.40
+2.81%
 
DAP.DE Danaher Corporation
237.45
+1.00%
 
RVTY Revvity, Inc.
122.70
+7.74%
 
WAT Waters Corporation
399.87
+5.13%
 
MEDP Medpace Holdings, Inc.
352.01
+0.32%
 
ILMN Illumina, Inc.
144.22
+5.51%